Annual report
4528.TEDINET S100VY8R
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Amended by S100W9NU (2025-07-01).
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥486.9bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥502.7bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥447.2bn | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥361.4bn | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥309.3bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥59.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥159.9bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥59.3bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥163.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥143.5bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥105.0bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥100.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥50.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥128.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥80.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥75.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥50.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥128.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.06T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥913.7bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥882.4bn | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥739.2bn | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥745.4bn | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥275.8bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥115.1bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥788.2bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥798.6bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥747.8bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥782.5bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥793.0bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥741.9bn | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥655.9bn | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥634.1bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥204.6bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥166.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥96.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥69.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥61.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥82.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥110.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥159.6bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥61.8bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥74.0bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥136.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥48.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥100.3bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥6.0bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥57.6bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | ¥94.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥89.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥32.5bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥60.2bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥24.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥106.55 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥266.61 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥230.85 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥162.19 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥151.11 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥106.41 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥266.57 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥230.79 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥162.16 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥151.09 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,665.61 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,688.43 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,519.19 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,343.4 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,270.45 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 73.5% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 86.8% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 84.1% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 88.7% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 85.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 6.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.1% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 4,287 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 3,853 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 3,761 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 3,687 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 3,607 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥451.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥498.8bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥441.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥357.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥305.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥114.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥187.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥112.3bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥188.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥150.8bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥121.1bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥86.8bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥127.5bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥198.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥102.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥152.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥117.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥94.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥76.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.03T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥847.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥804.6bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥661.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥669.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥229.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥97.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥797.6bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥750.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥685.6bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥599.2bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥574.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥172.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥184.8bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥218.02 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥318.51 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥239.96 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥190.51 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥154.1 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥217.98 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥318.49 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥239.94 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥190.49 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥154.08 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥80 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥56 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,697.77 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,597.16 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,403.84 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,226.79 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,150.68 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.2% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 498,692,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 498,692,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 517,425,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 528,341,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 528,341,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 3,464 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 3,437 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 3,381 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 3,354 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 3,319 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Productsreportable segment | employees | at 2025-03-31 | 4287 pure |
| Pharmaceutical Productsreportable segment | employees | at 2025-03-31 | 3464 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,977
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目４番５号 | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)あいおいニッセイ同和損害保険株式会社 (常任代理人日本マスタートラスト信託銀行株式会社) | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)東京都渋谷区恵比寿１丁目28番１号 (東京都港区赤坂１丁目８番１号赤坂インターシティAIR) | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)ステート ストリート バンク アンド トラスト カンパニー 505103 （常任代理人株式会社みずほ銀行） | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)１単元(100株)未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)小野薬品工業株式会社 | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)大阪市中央区道修町二丁目１番５号 | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Date of resolution dividends of surplus | FilingDateInstant_Row1Member | 2024-10-31 | |
| Resolution dividends of surplus | FilingDateInstant_Row1Member | Original text (Japanese)取締役会決議 | |
| Date of resolution dividends of surplus | FilingDateInstant_Row2Member | 2025-06-19 | |
| Resolution dividends of surplus | FilingDateInstant_Row2Member | Original text (Japanese)定時株主総会決議 | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember | Original text (Japanese)代表取締役取締役会長CEO | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember | Original text (Japanese)相 良 暁 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember | 1958-10-07 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember | Original text (Japanese)(注)3 | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember | Original text (Japanese)代表取締役取締役社長COO | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember | Original text (Japanese)滝 野 十 一 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember | 1968-01-14 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember | Original text (Japanese)(注)3 | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember | Original text (Japanese)代表取締役副社長執行役員経営戦略本部長兼人事統括部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember | Original text (Japanese)辻 中 聡 浩 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember | 1964-12-18 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember | Original text (Japanese)(注)3 | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000NomuraMasaoMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000NomuraMasaoMember | Original text (Japanese)野 村 雅 男 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000NomuraMasaoMember | 1949-08-02 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00945-000NomuraMasaoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000NomuraMasaoMember | Original text (Japanese)(注)3 | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000OkunoAkikoMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00945-000OkunoAkikoMember | Original text (Japanese)奥 野 明 子 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |